Timothy Eisen
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 7
- Cell Biology top 5%
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 4
-
- Renal cell carcinoma treatment 15
- Lung Cancer Treatments and Mutations 5
- Molecular Biology top 10%
- Renal and related cancers 5
- RNA modifications and cancer 5
-
- MRI in cancer diagnosis 3
- Co-authors
- Colin R. GodingNicola J. BentleyAthena MatakidouRichard S. HoulstonPeter BroderickYufei WangJayaram VijayakrishnanChristopher I. Amos
- Cited by
- Cancer ResearchCell BiologyOncology
- Journals
- Journal of Clinical Oncology (11 papers)British Journal of Cancer (5 papers)PLoS ONE (2 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Timothy Eisen
38 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 108
- Cancer Research 355
- Cell Biology 358
- Oncology 458
- Pulmonary and Respiratory Medicine 548
- Molecular Biology 1.1k
Countries citing papers authored by Timothy Eisen
This map shows the geographic impact of Timothy Eisen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Eisen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Eisen more than expected).
Fields of papers citing papers by Timothy Eisen
This network shows the impact of papers produced by Timothy Eisen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Eisen. The network helps show where Timothy Eisen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Timothy Eisen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 4 | |
| 2 | 2017 | 13 | |
| 3 | 2011 | 20 | |
| 4 | 2011 | 22 | |
| 5 | 2010 | 53 | |
| 6 | 2009 | 155 | |
| 7 | 2009 | 12 | |
| 8 | 2008 | 21 | |
| 9 | 2008 | 377 | |
| 10 | 2007 | 36 | |
| 11 | 2007 | 5 | |
| 12 | 2004 | 2 | |
| 13 | 2004 | 39 | |
| 14 | 2004 | 14 | |
| 15 | Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC) | 2002 | 21 |
| 16 | A phase III randomised comparison of gemcitabine/carboplatin with mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer | 2002 | 3 |
| 17 | 1997 | 26 | |
| 18 | 1997 | 18 | |
| 19 | 1996 | 13 | |
| 20 | Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine. | 1996 | 28 |
About Timothy Eisen
Timothy Eisen is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (15 papers), Cancer Genomics and Diagnostics (7 papers), Renal and related cancers (5 papers), RNA modifications and cancer (5 papers), Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and MRI in cancer diagnosis (3 papers). The work is most often cited by research in Cancer Research (355 citations), Cell Biology (358 citations) and Oncology (458 citations). Timothy Eisen has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Colin R. Goding, Nicola J. Bentley, Athena Matakidou, Richard S. Houlston, Peter Broderick, Yufei Wang, Jayaram Vijayakrishnan, Christopher I. Amos, Margaret R. Spitz and Emily L. Webb. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, PLoS ONE, Nature Reviews Urology and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.